Literature DB >> 11771419

Assay of RGS protein activity in vitro using purified components.

Andrejs M Krumins1, Alfred G Gilman.   

Abstract

Single-turnover and steady-state GTPase assays are an effective means to identify and characterize interactions between RGS and G alpha proteins in vitro. The advantage of the single turnover GTPase assay is that it permits simple and rapid assessment of RGS protein activity toward a putative G alpha-GTP substrate. Moreover, once an interaction between an RGS protein and a G alpha-GTP subunit has been identified, the single-turnover assay can be used to determine Michaelis-Menten constants and/or KI values for other competing G alpha substrates. A disadvantage of the single-turnover assay is that a negative result does not preclude the possibility of an interaction between given RGS and G alpha proteins in vivo. Inappropriate reaction conditions or the presence (or absence) of appropriate posttranslational modifications may result in small or undetectable increases in RGS protein-dependent GTPase activity. In these cases it may be tempting to examine RGS protein activity using steady-state GTPase assays in phospholipid vesicles reconstituted with receptors and heterotrimetric G proteins. The advantage to monitoring steady-state GTPase activity in reconstituted proteoliposomes is that ligand-dependent activation of the receptor facilitates GDP dissociation, such that effects of RGS proteins can be observed; multiple cycles of GTP binding and hydrolysis then amplify the GTPase signal. Additionally, the presence of the phospholipid membrane can increase the local RGS protein concentration approximately 10(4)-fold, permitting observation of interactions that are weak in solution. The primary disadvantage of the reconstituted system is the requirement for receptor purification, a technically demanding undertaking in comparison to the purification of G alpha, G beta gamma, and most RGS proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11771419     DOI: 10.1016/s0076-6879(02)44748-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  7 in total

1.  Resistance to inhibitors of cholinesterase 8A catalyzes release of Galphai-GTP and nuclear mitotic apparatus protein (NuMA) from NuMA/LGN/Galphai-GDP complexes.

Authors:  Gregory G Tall; Alfred G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

2.  Activation of the regulator of G protein signaling 14-Gαi1-GDP signaling complex is regulated by resistance to inhibitors of cholinesterase-8A.

Authors:  Christopher P Vellano; Feng-Jue Shu; Suneela Ramineni; Cindee K Yates; Gregory G Tall; John R Hepler
Journal:  Biochemistry       Date:  2011-01-11       Impact factor: 3.162

3.  A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration.

Authors:  Mikel Garcia-Marcos; Pradipta Ghosh; Jason Ear; Marilyn G Farquhar
Journal:  J Biol Chem       Date:  2010-02-15       Impact factor: 5.157

4.  GTPase acceleration as the rate-limiting step in Arabidopsis G protein-coupled sugar signaling.

Authors:  Christopher A Johnston; J Philip Taylor; Yajun Gao; Adam J Kimple; Jeffrey C Grigston; Jin-Gui Chen; David P Siderovski; Alan M Jones; Francis S Willard
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-19       Impact factor: 11.205

5.  A high throughput screen for RGS proteins using steady state monitoring of free phosphate formation.

Authors:  C Aaron Monroy; Duncan I Mackie; David L Roman
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  SUMO-SIM interactions regulate the activity of RGSZ2 proteins.

Authors:  Javier Garzón; María Rodríguez-Muñoz; Ana Vicente-Sánchez; María Ángeles García-López; Ricardo Martínez-Murillo; Thierry Fischer; Pilar Sánchez-Blázquez
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

7.  Evolutionary Conservation of a GPCR-Independent Mechanism of Trimeric G Protein Activation.

Authors:  Brantley D Coleman; Arthur Marivin; Kshitij Parag-Sharma; Vincent DiGiacomo; Seongseop Kim; Judy S Pepper; Jason Casler; Lien T Nguyen; Michael R Koelle; Mikel Garcia-Marcos
Journal:  Mol Biol Evol       Date:  2015-12-10       Impact factor: 16.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.